本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cogent Biosciences, Inc.

10.86
-0.1100-1.00%
盘后10.860.00000.00%17:14 EDT
成交量:173.21万
成交额:1,856.05万
市值:15.15亿
市盈率:-4.35
高:10.97
开:10.87
低:10.38
收:10.97
52周最高:12.97
52周最低:3.72
股本:1.39亿
流通股本:9,913.91万
量比:0.92
换手率:1.75%
股息:- -
股息率:- -
每股收益(TTM):-2.4950
每股收益(LYR):-2.4616
净资产收益率:-84.04%
总资产收益率:-47.45%
市净率:13.67
市盈率(LYR):-4.41

数据加载中...

2023/03/14

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/12

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/06

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/16

重要事件披露

8-K/A [Amend] - Current report
2022/06/15

重要事件披露

8-K - Current report
2022/06/14

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses